Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
US Army
UBS
Cipla
Baxter
Fuji
US Department of Justice
Merck
AstraZeneca

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016929

« Back to Dashboard

NDA 016929 describes FUDR, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the FUDR profile page.

The generic ingredient in FUDR is floxuridine. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the floxuridine profile page.
Summary for 016929
Tradename:FUDR
Applicant:Hospira
Ingredient:floxuridine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 016929

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Argus Health
Boehringer Ingelheim
Moodys
Accenture
Merck
Fish and Richardson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.